We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Bayer Recalls Liquid Leukine For Adverse Effects

Law360 (January 25, 2008, 12:00 AM EST) -- Bayer HealthCare announced Wednesday that it would withdraw the current liquid formulation of Leukine from the supply system in the United States, saying it had received an increase in reports of side effects such as fainting.

The company, having consulted with the U.S. Food and Drug Administration, sent a letter to health care professionals on Wednesday asking them to stop using the liquid medication and return any unused vials.

Leukine, a growth factor, enhances immune cell function and fights infections and disease in patients with acute...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.